Howard Capital Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$823K Buy
12,221
+8,361
+217% +$557K 0.01% 279
2026
Q1
$242K Sell
3,860
-5,268
-58% -$367K ﹤0.01% 301
2025
Q4
$606K Buy
9,128
+206
+2% +$13.3K 0.01% 289
2025
Q3
$600K Sell
8,922
-12
-0.1% -$950 0.01% 273
2025
Q2
$780K Sell
8,934
-534
-6% -$41.9K 0.01% 251
2025
Q1
$647K Sell
9,468
-1,453
-13% -$119K 0.02% 239
2024
Q4
$849K Buy
10,921
+317
+3% +$23.5K 0.01% 232
2024
Q3
$711K Buy
+10,604
New +$871K 0.01% 243

Other funds holding DXCM

Howard Capital Management's DXCM Position: Q2 2026 in Review

Howard Capital Management increased its DexCom (DXCM) stake by 217% in Q2 2026, buying an estimated $557K and bringing the position to 12,221 shares worth $823K. The position accounts for 0.01% of the portfolio, ranked #279.

Howard Capital Management first reported a position in DXCM in Q3 2024 and has held it in 8 quarters since. The position peaked at $849K in Q4 2024. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Howard Capital Management held 12,221 shares of DexCom worth $823K as of Q2 2026.
  • Howard Capital Management bought 8,361 DexCom shares in Q2 2026, an estimated $557K.
  • DexCom made up 0.01% of Howard Capital Management's portfolio in Q2 2026, its #279 holding.
  • Howard Capital Management first reported a position in DexCom in Q3 2024 and has held it in 8 quarters since.
  • Howard Capital Management's DexCom position peaked at $849K in Q4 2024.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Howard Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.